It looks like there is a request for a follow up for "Scientific Advice Letter". The request relates to "Pharmaceutical" and "Clinical" matters. There were 11 request for the "Scientific Advice Letters" for other items looking for approval.
Probably to be expected, and at least they didn't wait till the 11th hour to do it. Its moving, I think, hopefully.
- Forums
- ASX - By Stock
- TIS
- ema 21/11/2013
ema 21/11/2013, page-2
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online